- Transdermal fentanyl and respiratory arrest in adolescents. // WHO Drug Information;2004, Vol. 18 Issue 4, p275
Focuses on the report received by Health Canada on two cases of death suspected of being associated with the use of transdermal fentanyl system (Duragesic) prescribed off-level to adolescents. Indication of Duragesic for the management of chronic pain in patients requiring continuous opioid...
- Fentanyl-Related Deaths in Ontario, Canada: Toxicological Findings and Circumstances of Death in 112 Cases (2002-2004). Martin, Teri L.; Woodall, Karen L.; McLellan, Barry A. // Journal of Analytical Toxicology;Oct2006, Vol. 30 Issue 8, p603
The article focuses on toxicological findings and circumstances of death in 112 cases of fentanyl-related deaths in Ontario, Canada from 2002 to 2004. Fentanyl was quantitated in blood. The routes of administration of fentanyl include transdermal application of Duragesic patches, intravenous...
- Skin patch fights cancer's agony. // USA Today Magazine;Feb92, Vol. 120 Issue 2561, p14
Describes the Duragesic fentanyl transdermal system II for cancer victims suffering excruciating pain. Advantages of the transdermal patch method of releasing medication over other traditional methods; How it works.
- Bioequivalence Criteria for Transdermal Fentanyl Generics. Walter, Carmen; Felden, Lisa; Lötsch, Jörn // Clinical Pharmacokinetics;2009, Vol. 48 Issue 10, p625
With the increasing appearance of transdermal fentanyl generics since 2004 when patent protection of the reference DuragesicÂ® expired, opportunities to switch between different generics have arisen. Transdermal fentanyl is subject to bioequivalence regulation because only approximately 92%of...
- Respiratory Arrest caused by abuse of Fentanyl Patch: A Case Report. Duran, Arif; Ylldırım, Osman; Ocak, Tarık; Tekelioğlu, Ümit // National Journal of Physiology, Pharmacy & Pharmacology;2014, Vol. 4 Issue 1, p89
Fentanyl is a pure and selective Î¼ opioid receptor agonist that was discovered to identify an improved analgesic over morphine, an opioid frequently associated with histamine-release, bradycardia, hyper- or hypotension, and prolonged postoperative respiratory depression. It is 80-100 times...
- Fentanyl abuse. // Reactions Weekly;Feb2014, Vol. 1489 Issue 1, p18
The article presents a case study of a 26-year-old woman diagnosed with nervous system inhibition, respiratory arrest and coma developed while receiving excessive transdermal fentanyl.
- fentanyl (transdermal). // Davis's Drug Guide for Nurses, 10th edition;2007, p515
This article presents a nursing guide to the transdermal analgesic fentanyl. Drug information provided includes pharmacokinetics, contraindications or precautions, adverse reactions or side effects, interactions, and availability. Duragesic is a popular brand of the drug. Nursing implications...
- FENTANYL PATCHES TO SEE TIGHTER REGULATION. Goldberg, Stephanie // Business Insurance;11/9/2015, Vol. 49 Issue 23, p0039
The article reports that the drug brand Duragesic (fentanyl transdermal patches) was reclassified by the U.S. Work Loss Data Institute's Official Disability Guidelines effective February 1, 2016.
- More Fentanyl Patch Overdoses Spur New Warning. // RN;Aug2007, Vol. 70 Issue 8, p28
The article focuses on the warning issued by the Institute for Safe Medication Practices concerning the inappropriate prescription of fentanyl (Duragesic) transdermal patches. The patches has produced adverse and sometimes fatal outcomes. Ortho-McNeil, the producer of Duragesic has added a boxed...
- Transdermal Fentanyl in Palliative Care: A Series of Five Cases. O'Síoráin, L. // Clinical Drug Investigation;1998, Vol. 16 Issue 1, p88
Demonstrates several clinical cases of the role of transdermal fentanyl in palliative care. Use of transdermal fentanyl in conjunction with oral and subcutaneous opiates; Benefits of fentanyl over morphine; Tendency to cause respiratory depression.